Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Bimzelx was previously approved by the FDA in October 2023 for adult patients with plaque psoriasis who are candidates for systemic therapy or phototherapy
IV and SQ NAD+ are often cycled: IV: Weekly during loading, then monthly SQ: 23x per week as needed This layered method supports consistent NAD+ levels without oversaturation
This therapy should not be used during pregnancy or breastfeeding
For a 4mg dose: 4mg / 5mg per mL = 0.8mL = 80 units
For research-use vial math involving a separate cagrilintide and retatrutide blend, use the Cagri-Reta blend dosage calculator
US$ 23.84
US$ 28.85
US$ 28.12
US$ 27.83
US$ 28.66
